Products & Tech | Page 63 of 63

Takeda and Amylin to Co-develop Obesity Treatments

Amylin Pharmaceuticals, Inc. and Takeda Pharmaceuticals Company Limited announced an agreement to co-develop and commercialize pharmaceutical products for the treatment of obseity and related conditions. Amylin, whose top product, Byetta, had sales of $678.5 million last year. will receive a one-time up-front payment of $75 million from Takeda, the largest pharmaceutical

Isis Pharmaceuticals: Positive Phase 2 Data for ISIS 113715

Isis pharmaceuticals announced positive mid-stage trial results for the drug called ISIS 113715. The drug, tested on Type 2 diabetics with poor glucose control, not only lowered blood glucose, but also caused reductions in LDL cholesterol and a tendency towards weight loss. Robert Henry, M.D., Professor of Medicine, University of California at San Diego and Chief, Section of Diabetes,

Merck’s Diabetes Drug Januvia Linked to Pancreatitis

The FDA announced yesterday that it has received 88 reports of pancreatitis (inflammation of the pancreas) in patients taking the drugs Januvia (or Janumet). Many of these patients required hospitalization and 53% of the cases resolved once the drug was discontinued....